People‑centered cancer research: the value of individuality
People‑centered cancer research: the value of individuality
Cancer research is evolving rapidly. Advances in technology and deeper biological understanding are increasingly accompanied by a growing focus on the lived experiences of people affected by cancer. There is growing recognition that evidence must reflect individual experience, variability, and context if it is to meaningfully inform care.
The idea of being “United by Unique”, the theme of World Cancer Day 2026, reflects this shift, highlighting the importance of research that recognizes individuality across diagnosis, treatment, and survivorship. While cancer is a shared global challenge, each person’s experience is shaped by a distinct combination of biological, social, and personal factors.
People‑centered cancer care is increasingly prompting researchers, clinicians, and policymakers to rethink how evidence is generated, interpreted, and communicated. It encourages approaches that better reflect the diversity of patient needs, the complexity of survivorship, and the role of communication in supporting informed decision‑making.
Evidence informed by the full range of patient experiences
Variability is a defining feature of survivorship, lifestyle, and rehabilitation research. Age, comorbidities, treatment exposure, baseline function, and social context all influence how individuals experience cancer and respond to interventions.
This view is reflected in the work of Justin C. Brown, Director of the Exercise and Cancer Biology Program at AdventHealth and PLOS One Section Editor, and James Brenton, senior group leader at the Cancer Research UK Cambridge Institute and PLOS Medicine Academic Editor. Together, their perspectives emphasize that understanding inter‑individual differences is critical for generating evidence that is meaningful in real‑world contexts, including outcomes that matter to patients such as functional capacity, symptom burden, and long‑term well-being, alongside traditional clinical endpoints.
Recent epidemiological research further illustrates how patient characteristics fundamentally shape cancer risk and diagnostic outcomes. In the PLOS One article, Impact of patients’ age and comorbidities on prostate cancer overdiagnosis in clinical practice, researchers examined real‑world Prostate-Specific Antigen (PSA) testing and found that overdiagnosis was substantially more common among older adults and individuals with multiple comorbidities. These groups were also more likely to undergo additional imaging and follow‑up procedures with limited clinical benefit.
By showing how life expectancy, health status, and diagnostic pathways interact, the study underscores the need for screening and diagnostic strategies that account for individual context rather than relying on one‑size‑fits‑all approaches.
Interdisciplinary collaboration and patient involvement
Progress in people‑centered cancer research increasingly depends on collaboration across disciplines. Oncology, rehabilitation science, behavioral medicine, physiology, implementation science, and patient advocacy each contribute essential perspectives. When these fields work together, they create opportunities to generate more holistic and translatable evidence.
Patient involvement strengthens this work further. Co‑production—engaging patients in shaping research questions, interpreting findings, and contextualizing results—helps ensure that studies reflect the lived realities of those most affected by cancer. This approach supports research that is not only scientifically robust, but also relevant, respectful, and grounded in real‑world experience.
People-centered research in practice
Recent research offers clear examples of how people‑centered approaches are reshaping the evidence base for cancer care. In the recent study, Screening for anxiety in patients with cancer: Diagnostic accuracy of GAD‑7 items considering lowered GAD‑7 cut‑offs, researchers examined how adjusting GAD‑7 thresholds can improve the identification of anxiety among people undergoing treatment.
A complementary perspective is offered in Getting back on track after treatment of cancer: A qualitative interview study of cancer survivors’ experiences. Through in‑depth interviews, researchers explored how individuals navigate life after treatment, including rebuilding routines, managing ongoing effects, and regaining identity.
Together, studies such as these contribute to an evidence base that better reflects the diversity of people living with and beyond cancer.
Trust built through patient‑informed, transparent communication
Clear and accessible communication is essential if research findings are to be understood and applied appropriately by clinicians, patients, and wider audiences. Lifestyle and exercise research can be vulnerable to misinterpretation without sufficient precision or context, making approaches such as plain‑language summaries and visual formats important for broadening the reach of scientific work without compromising rigor.
“Research findings must be communicated in ways that are precise but accessible, clearly distinguishing between what is known, what is emerging, and what remains uncertain.”
Justin C. Brown, PLOS One Editor
Looking ahead
As cancer research continues to evolve, there is increasing emphasis on approaches that are personalized, collaborative, and attentive to life experience. By embracing variability, refining tools for real‑world contexts, and elevating diverse perspectives, researchers are contributing to an evidence base that is both rigorous and responsive. This work reflects a broader shift toward cancer research that increasingly recognizes individuality as a core consideration in generating meaningful evidence.
This commentary is based on the PLOS One blog post, World Cancer Day 2026: Continuing the theme of “United by Unique”.
Join the PLOS One research community
Connect with researchers and clinicians from around the world. Receive curated content and the latest updates that keep you connected to research across the scope of the journal - delivered straight to your inbox.
“Join our inclusive, multidisciplinary community of authors committed to making their work open, discoverable, and accessible.”
Emily Chenette, Editor-in-Chief,
PLOS One
Explore further
20 years of advancing rigorous science
Discover curated open access research and commentaries addressing real-world questions across disciplines.
